| Dr Joseph Michael Radley, MD | |
|
6051 U S Highway 49, Hattiesburg, MS 39401-7201 | |
| (601) 288-2690 | |
| (601) 288-2695 |
| Full Name | Dr Joseph Michael Radley |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 6051 U S Highway 49, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346655792 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | A168321 (California) | Secondary |
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | 29080 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fgh Trauma Surgery Clinic | 7517916331 | 12 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Save the Children and its animal ambassador Lassie hosted fun "Prep Rally" events here this week to help local children build resiliency and feel safe as the city commemorates the 10-year anniversary of Hurricane Katrina.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Household mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports.
› Verified 9 days ago
| Entity Name | Forrest County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295837631 PECOS PAC ID: 1052397767 Enrollment ID: O20040624001351 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Save the Children and its animal ambassador Lassie hosted fun "Prep Rally" events here this week to help local children build resiliency and feel safe as the city commemorates the 10-year anniversary of Hurricane Katrina.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Household mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports.
› Verified 9 days ago
| Entity Name | Fgh Trauma Surgery Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427090398 PECOS PAC ID: 7517916331 Enrollment ID: O20050119000801 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Save the Children and its animal ambassador Lassie hosted fun "Prep Rally" events here this week to help local children build resiliency and feel safe as the city commemorates the 10-year anniversary of Hurricane Katrina.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Household mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Michael Radley, MD 4860 Y St Ste 3800, Sacramento, CA 95817-2307 Ph: (916) 734-2807 | Dr Joseph Michael Radley, MD 6051 U S Highway 49, Hattiesburg, MS 39401-7201 Ph: (601) 288-2690 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Save the Children and its animal ambassador Lassie hosted fun "Prep Rally" events here this week to help local children build resiliency and feel safe as the city commemorates the 10-year anniversary of Hurricane Katrina.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
Household mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports.
› Verified 9 days ago
Jeffrey A Burns, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5003 Hardy St Ste 401, Hattiesburg, MS 39402 Phone: 601-296-2100 Fax: 601-296-2106 | |
David W Bomboy, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Dr. Michael C Patterson, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7400 Fax: 601-554-7488 | |
James S Williford, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Thomas Payne Royals, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 103 Tatum Rd, Hattiesburg, MS 39401 Phone: 601-268-5630 Fax: 601-268-5819 | |
Dr. James A Antinnes, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7451 Fax: 601-554-7488 | |
Dr. James N Sikes, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7400 Fax: 601-554-7488 |